Blocking and suppressing mechanisms of chemoprevention by dietary constituents

M M Manson1, A Gescher, E A Hudson

  • 1MRC Toxicology Unit, CMHT Hodgkin Building, University of Leicester, Lancaster Road, PO Box 138, Leicester, UK. mmm2@le.ac.uk

Toxicology Letters
|March 18, 2000
PubMed

Insights

Dietary compounds show chemopreventive potential by blocking cancer initiation and suppressing tumor growth through various mechanisms. Understanding these actions enhances disease prevention strategies and dietary recommendations.

Area of Science:

  • Nutritional biochemistry
  • Cancer prevention research

Background:

  • Dietary constituents demonstrate chemopreventive effects in animal models and cell cultures.
  • Compounds can act as blocking agents (preventing initiation) or suppressing agents (reducing proliferation).
  • Many compounds exhibit dual blocking and suppressing activities.

Purpose of the Study:

  • To explore the mechanisms of action for dietary chemopreventive compounds.
  • To understand how these compounds affect cellular processes relevant to carcinogenesis.

Main Methods:

  • Review of studies on dietary constituents in animal models and cell cultures.
  • Analysis of biochemical mechanisms, including drug metabolism, reactive oxygen species scavenging, and signal transduction pathways.

Main Results:

  • Blocking agents alter drug metabolism and scavenge reactive oxygen species.
  • Suppressing agents modulate signal transduction, affecting gene expression, cell cycle arrest, and apoptosis.
  • Compounds often possess both blocking and suppressing activities.

Conclusions:

  • Improved understanding of dietary components' effects on cell biochemistry increases the success of chemoprevention trials.
  • Knowledge gained can inform public dietary advice for optimizing disease prevention.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...